Evaluation of performances of VERSANT HCV RNA 1.0 assay (kPCR) and Roche COBAS AmpliPrep/COBAS TaqMan HCV test v2.0 at low level viremia

被引：0
|
作者：
Mazzuti, Laura [1 ]
Lozzi, Maria Antonietta [2 ]
Riva, Elisabetta [3 ]
Maida, Paola [1 ]
Falasca, Francesca [1 ]
Antonelli, Guido [1 ]
Turriziani, Ombretta [1 ]
机构：
[1] Sapienza Univ Rome, Dept Mol Med, Rome, Italy
[2] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy
[3] Univ Campus Biomed Rome, Rome, Italy
来源：
NEW MICROBIOLOGICA | 2016年 / 39卷 / 03期
关键词：
HCV; Viral load; Real-time PCR; VERSANT HCV RNA; COBAS TaqMan HCV; RESIDUAL VIREMIA; THERAPY;
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
We assess the concordance between low level HCV values obtained using the VERSANT HCV RNA 1.0 Assay (kPCR) and COBAS AmpliPrep/COBAS TaqMan HCV Quantitative Test v2.0. The correlation between the values obtained by the two RT-PCR assays for samples with quantifiable HCV RNA levels revealed that viral load measured by kPCR significantly correlated with that of the CAP/CTM (R=0.644, P<0.0001). The results show a good concordance (n=126/144, 87%); discordant results were mainly observed in the assessment of values below the lower limit of detection of the assays. These variations may have an impact on clinical decisions for patients on HCV triple therapy or interferon-free regimens. It is therefore recommended to monitor individual patients with the same test throughout treatment.
引用
收藏
页码：224 / 227
页数：4
相关论文
共 50 条
  • [21] Evaluation of the Fluorion HCV QNP v3.0 real-time PCR assay for quantifying HCV RNA in Moroccan patients: A comparative study with COBAS AmpliPrep/COBAS TaqMan HCV v2.0
    Madihi, Salma
    Boukaira, Samia
    Bouafi, Hind
    Baha, Warda
    Belkadi, Bouchra
    Benani, Abdelouaheb
    [J]. GENE REPORTS, 2024, 36
  • [22] HCV RNA detection in HCV antibody-positive patients with the COBAS® AmpliPrep/COBAS® TaqMan® HCV test, v2.0 in comparison with FDA-approved nucleic acid tests
    Butcher, Ann
    Aslam, Shagufta
    Hemyari, Pari
    Cowen, Ula
    Heilek, Gabrielle
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2014, 60 (04) : 336 - 340
  • [23] Cobas Ampliprep/Cobas TaqMan HIV-1 v2.0 Assay: Consequences at the Cohort Level
    Taylor, Ninon
    Grabmeier-Pfistershammer, Katharina
    Egle, Alexander
    Greil, Richard
    Rieger, Armin
    Ledergerber, Bruno
    Oberkofler, Hannes
    [J]. PLOS ONE, 2013, 8 (08):
  • [24] The ExPECT Study: An International multicenter clinical trial evaluating low HCV RNA viremia with the COBAS® AmpliPrep/COBAS® TaqMan® HCV Test, v2.0 compared to assays used in routine clinical practice and drug trials
    Wedemeyer, Heiner
    Kessler, Harald H.
    Michel-Treil, Veronique
    Bremer, Birgit
    Huebner, Margit
    Helander, Anna
    Khiri, Hacene
    Sunga, June
    Aslam, Shagufta
    Cobb, Bryan R.
    Halfon, Philippe
    [J]. HEPATOLOGY, 2012, 56 : 676A - 677A
  • [25] HCV RNA measurement in samples with diverse genotypes using versions 1 and 2 of the Roche COBAS® AmpliPrep/COBAS® TaqMan® HCV test
    Pyne, Michael T.
    Mallory, Melanie
    Hillyard, David R.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2015, 65 : 54 - 57
  • [26] Evaluation of the COBAS hepatitis C virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays
    Konnick, EQ
    Williams, SM
    Ashwood, ER
    Hillyard, DR
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (05) : 2133 - 2140
  • [27] Impact of hepatitis C virus (HCV) genotypes on quantification of HCV RNA in serum by COBAS AmpliPrep/COBAS TaqMan HCV test, Abbott HCV RealTime assay, and VERSANT HCV RNA assay (vol 45, pg 3077, 2007)
    Tuaillon, Edouard
    Mondain, Anne-Marie
    Ottomani, Laure
    Roudiere, Laurent
    Perney, Pascal
    Picot, Marie-Christine
    Seguret, Fabienne
    Blanc, Francois
    Larrey, Dominique
    de Perre, Philippe Van
    Ducos, Jacques
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (12) : 4096 - 4096
  • [28] Evaluation of the Abbott Realtime HCV IUO M2000SP/RT Assay Comparison with the Roche HCV IVD COBAS® AmpliPrep/COBAS® Taqman HCV Assay
    Pancholi, P.
    LaRue, H.
    Rigali, L.
    Ilasat, J. Balada
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 889 - 889
  • [29] Differences between quantification of genotype 3 hepatitis C virus RNA by Versions 1.0 and 2.0 of the COBAS AmpliPrep/COBAS TaqMan HCV Test
    Pierce, Virginia M.
    Eversley, Jacqueline S.
    Tran, Thuy K.
    Rosenberg, Eric S.
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (07) : 956 - 961
  • [30] Multicenter Evaluation of Cobas HCV Real-Time PCR Assay on the Roche Cobas 4800 System in Comparison with COBAS AmpliPrep/COBAS TaqMan HCV Test: Leading Circle for Cobas 4800 Virology (LCCV) Project
    Lee, W.
    Baek, J.
    Kim, H.
    Hur, M.
    Bae, E.
    Lee, K.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 983 - 983
12345